Related Experiment Video
Updated: Jul 9, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
Peripheral atherectomy: a critical review
Troy A Bunting1, Lawrence A Garcia
1Division of Cardiology and Vascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02135, USA.
Insights
Atherectomy shows promise for peripheral artery disease, offering advantages over traditional treatments. However, more long-term data is needed for widespread acceptance of these endovascular therapies.
Area of Science:
- Endovascular therapy
- Peripheral arterial disease management
- Atherectomy technologies
Background:
- Atherectomy is gaining traction among endovascular specialists for treating peripheral arteries.
- It offers theoretical advantages over coronary applications, especially for infra-inguinal peripheral arterial disease.
- Traditional treatments like angioplasty and stenting face challenges such as restenosis in peripheral circulation.
Purpose of the Study:
- To review the current status and potential of atherectomy in peripheral arterial disease.
- To highlight the limitations of existing studies and the need for further research.
- To assess the suitability of atherectomy for complex peripheral arterial lesions.
Main Methods:
- Review of existing literature on atherectomy devices (e.g., SilverHawk) and laser atherectomy.
- Analysis of short-term outcomes and identification of gaps in long-term data.
- Discussion of the physiological challenges in peripheral arterial disease impacting treatment success.
Main Results:
- The SilverHawk atherectomy device shows promising short-term results, but long-term data is limited.
- Laser atherectomy has niche applications, yet study numbers are restricted.
- Existing athero-ablative technologies lack definitive long-term outcome data.
Conclusions:
- Atherectomy presents a viable therapeutic option for peripheral arterial disease.
- Further objective, long-term outcome data (12 months and beyond) is crucial for scientific acceptance.
- Continued research is necessary to establish the definitive role of atherectomy in peripheral interventions.
Abstract:
Atherectomy is experiencing increased interest from endovascular specialists as a therapeutic treatment in the peripheral arteries. Long studied in the coronary vasculature, atherectomy has several theoretical advantages that make it uniquely suited for the peripheral circulation. In particular, infra-inguinal peripheral arterial disease experiences physiologic stresses and forces that have made traditional percutaneous coronary treatments such as angioplasty and stenting not as successful. Restenosis has been a major problem for angioplasty and stenting alone. The SilverHawk atherectomy device has favorable short-term data but important longer-term data are limited and need further study. Laser atherectomy also has favorable applications in niche patients but the number of studies is limited. Unfortunately, athero-ablative technologies for peripheral arterial disease require more definitive objective data regarding 12-month and longer-term outcomes in order to obtain widespread scientific acceptance.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Atherosclerosis III: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
